作者: Ad C. Fluit , Mark E. Jones , Franz-Josef Schmitz , Jacques Acar , Renu Gupta
关键词:
摘要: The SENTRY Antimicrobial Surveillance Program was established to monitor the occurrence and antimicrobial susceptibility of bacterial pathogens via an international network sentinel hospitals. Twenty European hospitals referred a total 887 urinary tract infection (UTI) isolates reference laboratory during period October–December 1997. Ninety percent species were represented by Escherichia coli (52%), Enterococcus spp. (12%), Klebsiella (7%), Proteus Pseudomonas aeruginosa Enterobacter (5%). E. penicillins less than 60%, while almost all susceptible piperacillin/tazobactam (98% susceptibility), cephalosporins (98%), carbapenems (100%). Amikacin best aminoglycoside (99.8% susceptibility). quinolones only 88–89%, with highest levels resistance observed for from Portugal, Italy, England, Netherlands, some centers in France, Spain, Poland. newer generations 82–95% 100%. again (94% any s-lactam antibiotic poor, except (100% susceptibility) cefepime (90% aminoglycosides 80–89%. showed complete cefepime, ceftriaxone, carbapenems, piperacillin/tazobactam, P. results (susceptibility 89%), 84%), amikacin ticarcillin both 80%). vancomycin teicoplanin ampicillin (94%).